期刊文献+

原发性高血压患者血清8-异构前列腺素F2α测定的临床意义

暂未订购
导出
摘要 目的探讨原发性高血压患者血清中8-异构前列腺素F2α(8-iso—PGF2α)改变的临床意义。方法选取124例原发性高血压患者(分为1,2,3级)和50例正常健康者,应用双抗体夹心酶联免疫吸附法(ELISA)检测患者血清8-iso—PGF2α的水平。结果原发性高血压1级、2级和3级患者的血清8-iso—PGF2α水平分别为(18.5±4.7)ng/L、(29.3±7.7)ng/L和(40.8±10.6)ng/L,其差异均具有统计学意义(P〈0.05);原发性高血压患者的血清8-iso—PGF2α水平高于正常对照组(P〈0.05),且与血压水平呈正相关(r=0.385,P〈0.05)。结论血清8-iso—PGF2α水平增高与原发性高血压病程呈正相关,有利于高血压病情的评估。
作者 刘建武
出处 《中国医学创新》 CAS 2010年第8期118-119,共2页 Medical Innovation of China
  • 相关文献

参考文献6

  • 1Pratico D.F2-isopmstanes:sensitive and specific noninvasive indices of lipid peroxidation in vivo.Atherosclemsis,1999,147(1):1-10.
  • 2陈琳,匡希斌.异构前列腺素与临床氧化应激性损伤疾病[J].中国动脉硬化杂志,2005,13(5):667-669. 被引量:13
  • 3RomenJ JC,Reekelhof JF.Oxidative stress may explain how hypertension is maintained nomlalleve-ofangiotemin II.Braz J Med Biol Res,2000,33(6):653-660.
  • 4Schwedhelm E,Tsikas D,Durand T,et al.Tandem mass spectrometric quantification of 8-iso-pristaglandin F2α and its metabolite 2,3-dinor-5,6-dihydro,8-isoprostaglanin F2α in human urine.J Chromatograph B,2000,744:99-112.
  • 5陈玲玲,肖昕,向军俭.8-异前列腺素F_(2α)的检测及其临床价值[J].国际检验医学杂志,2004,26(5):408-410. 被引量:17
  • 6McKinney ET,Shouri R,Hunt RS,et al.Plasma urinary,and salivary 8-isoprostaglandin F-alpha level in normotensive and preeclamptic pregnancies.Am J Obstet Gynecol,2000,183 (4):874-877.

二级参考文献20

  • 1Yin H, Havrilla CM, Gao L, Morrow JD, Porter NA. Mechanisms for the formation of isoprostane endoperoxides from arachidonic acid. J Biol Chem, 2003, 278 (19): 16 720-725.
  • 2Roberts II LJ, Montine TJ, Markesbery WR, Tapper AR, Pierre Hardy, Sylvain Chemtob, et al. Formation of isoprostane-like compounds (Neuroprostanes) in Vivo from docosahexaenoic acid. J Biol Chem, 1998, 273 (22): 13 605-612.
  • 3Carlo Patrono, FitzGerald GA. Isoprostanes: Potential markers of oxidant stress in atherothrombotic disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 1997, 17 (11): 2 309-315.
  • 4Weber TJ, Markillie LM. Regulation of activator protein-1 by 8-iso-prostaglandin E2 in a thromboxane A2 receptor-dependent and independent. Molecular Pharmacology, 2003, 63 (5): 1 075-081.
  • 5Domenico Pratico, Lawson JA, FitzGerald GA. Cylooxygenase-dependent formation of the isoprostane, 8-epi prostaglandin F. Biochemistry and Molecular Biology, 1995, 270 (17): 9 800-808.
  • 6O'Donnell VB, Freeman BA. Interactions between nitric oxide and lipid oxidation pathways-implications for vascular disease. Circ Res, 2001, 88 (1): 12-21.
  • 7Scholz H, Yndestad A, Damas JK, Waehre T, Tonstad S, Aukrust P, et al. 8-Isoprostane increases expression of interleukin-8 in human macrophages through activation of mitogen-activated protein kinases. Cardiovascular Research, 2003, 59 (4): 945-954.
  • 8Audoly LP, Rocca B, Fabre JE, Koller BH, Thomas D, Loeb AL, et al. Cardiovascular responses to the isoprostanes iPF (2alpha)-III and iPE (2)-III are mediated via the thromboxane A(2) receptor in vivo. Circulation, 2000, 101 (24): 2 833-840.
  • 9Reilly MP, Delanty N, Roy L, Rokach J, Callaghan PO, Crean P, Lawson JA. Increased formation of the isoprostanes IPF2 -I and 8-Epi-prostaglandin F2 in acute coronary angioplasty evidence for oxidant stress during coronary reperfusion in humans. Circulation, 1997, 96 (10): 3 314-320.
  • 10Haas JA, Krier JD, Bolterman RJ, Juncos LA, Romero JC. Low-dose angiotensin Ⅱ increases free isoprostane levels in plasma. Hypertension, 1999, 34 (4Pt2): 983-986.

共引文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部